Answers are grounded in this paper and cite their sources.
Background & Aims: COVID-19 infection is associated with multiple cardiovascular complications that can impact mortality in patients admitted to intensive care units.This study aimed to investigate the relationship between NT-pro BNP levels and in-hospital outcomes (discharge or death) and changes in left ventricular ejection fraction (LVEF) in COVID-19 patients admitted to intensive care units. Materials and Methods:A cross-sectional study was conducted on 56 patients with PCR-confirmed COVID-19 and radiological evidence.Patients with a history of previous cardiovascular disease were excluded from the study.NT-pro BNP levels were measured within the first 24 hours of admission, and their association with LVEF and hospital outcomes was analyzed.Results:The mean NT-Pro BNP protein level in discharged COVID-19 patients was 1997.04 456.72 Pg/mL, and in deceased patients was 4417.17 1657.67 Pg/mL (P = 0.04).Discussion and Conclusion: The results of this study showed that elevated NT-pro BNP levels can be used as a predictive marker to identify patients at risk of death in intensive care units.Further studies are recommended to determine the clinical certainty of this indicator.
No takes yet. Share an insight, caveat, or question.
Soleimany et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: